143 related articles for article (PubMed ID: 2209608)
21. Chymotryptic cleavage of lipoprotein lipase. Identification of cleavage sites and functional studies of the truncated molecule.
Lookene A; Bengtsson-Olivecrona G
Eur J Biochem; 1993 Apr; 213(1):185-94. PubMed ID: 8477692
[TBL] [Abstract][Full Text] [Related]
22. Functional analyses of human apolipoprotein CII by site-directed mutagenesis: identification of residues important for activation of lipoprotein lipase.
Shen Y; Lookene A; Nilsson S; Olivecrona G
J Biol Chem; 2002 Feb; 277(6):4334-42. PubMed ID: 11719505
[TBL] [Abstract][Full Text] [Related]
23. A deletion of one nucleotide results in functional deficiency of apolipoprotein CII (apo CII Toronto).
Cox DW; Wills DE; Quan F; Ray PN
J Med Genet; 1988 Oct; 25(10):649-52. PubMed ID: 3225819
[TBL] [Abstract][Full Text] [Related]
24. Amino acid sequences surrounding the cAMP-dependent and calcium/calmodulin-dependent phosphorylation sites in rat and bovine synapsin I.
Czernik AJ; Pang DT; Greengard P
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7518-22. PubMed ID: 3118371
[TBL] [Abstract][Full Text] [Related]
25. [Apolipoproteins AI, B100, CII, CIII and E in human cerebrospinal fluid].
Liu Y; Liu B; Yin J; Wu K; Wu L
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):352-4. PubMed ID: 1814810
[TBL] [Abstract][Full Text] [Related]
26. Primary structure of murine major histocompatibility complex alloantigens: amino acid sequence of the amino-terminal one hundred and seventy-three residues of the H-2Kb glycoprotein.
Uehara H; Ewenstein BM; Martinko JM; Nathenson SG; Coligan JE; Kindt TJ
Biochemistry; 1980 Jan; 19(2):306-15. PubMed ID: 6986168
[TBL] [Abstract][Full Text] [Related]
27. C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase.
Cheng Q; Blackett P; Jackson KW; McConathy WJ; Wang CS
Biochem J; 1990 Jul; 269(2):403-7. PubMed ID: 2386483
[TBL] [Abstract][Full Text] [Related]
28. Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes.
Protter AA; Levy-Wilson B; Miller J; Bencen G; White T; Seilhamer JJ
DNA; 1984 Dec; 3(6):449-56. PubMed ID: 6439535
[TBL] [Abstract][Full Text] [Related]
29. Primary and tertiary structure of the principal human adenylate kinase.
Von Zabern I; Wittmann-Liebold B; Untucht-Grau R; Schirmer RH; Pai EF
Eur J Biochem; 1976 Sep; 68(1):281-90. PubMed ID: 183954
[TBL] [Abstract][Full Text] [Related]
30. Indices related to apo CII and CIII serum concentrations and coronary heart disease: a case-control study.
Gerber Y; Goldbourt U; Segev S; Harats D
Prev Med; 2003 Jul; 37(1):18-22. PubMed ID: 12799125
[TBL] [Abstract][Full Text] [Related]
31. Rat liver and small intestine produce proapolipoprotein A-I which is slowly processed to apolipoprotein A-I in the circulation.
Sliwkowski MB; Windmueller HG
J Biol Chem; 1984 May; 259(10):6459-65. PubMed ID: 6427215
[TBL] [Abstract][Full Text] [Related]
32. Cloning and sequencing of bovine apolipoprotein E complementary DNA and molecular evolution of apolipoproteins E, C-I, and C-II.
Yang YW; Chan L; Li WH
J Mol Evol; 1991 Jun; 32(6):469-75. PubMed ID: 1908018
[TBL] [Abstract][Full Text] [Related]
33. The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III.
Elshourbagy NA; Walker DW; Boguski MS; Gordon JI; Taylor JM
J Biol Chem; 1986 Feb; 261(5):1998-2002. PubMed ID: 3080432
[TBL] [Abstract][Full Text] [Related]
34. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
[TBL] [Abstract][Full Text] [Related]
35. A new fluorometric method for measuring the action of C apolipoproteins on milk lipoprotein lipase.
Lambert DA; Catapano AL; Smith LC; Sparrow JT; Gotto AM
Clin Chim Acta; 1997 Aug; 264(1):75-90. PubMed ID: 9267705
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
37. Human class 1 heparin-binding growth factor: structure and homology to bovine acidic brain fibroblast growth factor.
Harper JW; Strydom DJ; Lobb RR
Biochemistry; 1986 Jul; 25(14):4097-103. PubMed ID: 2427112
[TBL] [Abstract][Full Text] [Related]
38. [The distribution of apolipoproteins AI, CII and CIII mRNA in rat tissues].
Peng T; Liu B; Lan T
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):232-4. PubMed ID: 1748403
[TBL] [Abstract][Full Text] [Related]
39. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
Somekawa Y; Umeki H; Kobayashi K; Tomura S; Aso T; Hamaguchi H
J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
[TBL] [Abstract][Full Text] [Related]
40. Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls.
Xu CF; Angelico F; Del Ben M; Humphries S
Genet Epidemiol; 1993; 10(2):113-22. PubMed ID: 8339925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
